DE60331669D1 - Identifikation von Arzneimittel gegen Mykobakterien - Google Patents

Identifikation von Arzneimittel gegen Mykobakterien

Info

Publication number
DE60331669D1
DE60331669D1 DE60331669T DE60331669T DE60331669D1 DE 60331669 D1 DE60331669 D1 DE 60331669D1 DE 60331669 T DE60331669 T DE 60331669T DE 60331669 T DE60331669 T DE 60331669T DE 60331669 D1 DE60331669 D1 DE 60331669D1
Authority
DE
Germany
Prior art keywords
rv2027c
devr
devs
degree
single domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331669T
Other languages
English (en)
Inventor
Jaya S Tyagi
Deepak K Saini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60331669D1 publication Critical patent/DE60331669D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60331669T 2002-10-16 2003-10-16 Identifikation von Arzneimittel gegen Mykobakterien Expired - Lifetime DE60331669D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41883702P 2002-10-16 2002-10-16
PCT/IB2003/004555 WO2004036224A2 (en) 2002-10-16 2003-10-16 Screening method

Publications (1)

Publication Number Publication Date
DE60331669D1 true DE60331669D1 (de) 2010-04-22

Family

ID=32107981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331669T Expired - Lifetime DE60331669D1 (de) 2002-10-16 2003-10-16 Identifikation von Arzneimittel gegen Mykobakterien

Country Status (7)

Country Link
US (1) US7566550B2 (de)
EP (1) EP1554586B1 (de)
CN (1) CN100554966C (de)
AT (1) ATE460671T1 (de)
AU (1) AU2003269346A1 (de)
DE (1) DE60331669D1 (de)
WO (1) WO2004036224A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009035742A2 (en) * 2007-06-22 2009-03-19 The Uab Research Foundation Modulating latency and reactivation of mycobacterium tuberculosis
CN103983627A (zh) * 2008-06-17 2014-08-13 韩国巴斯德研究所 作为抗结核病药的吡啶并嘧啶化合物
JP5867730B2 (ja) * 2010-06-29 2016-02-24 国立研究開発法人産業技術総合研究所 ハロゲン化物の検出剤、並びにそれを検出する方法及び検出センサー
EP3050565A1 (de) * 2015-01-27 2016-08-03 Ecole Polytechnique Fédérale de Lausanne (EPFL) Benzimidazolschwefelderivate zur Vorbeugung oder Behandlung von Tuberkulose
WO2016182819A2 (en) * 2015-05-05 2016-11-17 William Marsh Rice University Identifying ligands from bacterial sensors
WO2020202188A1 (en) * 2019-03-29 2020-10-08 Indian Institute Of Science In-vitro processes for screening candidate molecules
CN114008446A (zh) * 2019-04-09 2022-02-01 新加坡科技研究局 采用表面增强拉曼光谱的分枝杆菌无标签检测

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975280A (en) * 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
US6043045A (en) * 1996-09-12 2000-03-28 The Scripps Research Institute Screening methods for the identification of novel antibiotics
US6162627A (en) * 1998-03-19 2000-12-19 University Of Medicine And Dentistry Of New Jersey Methods of identifying inhibitors of sensor histidine kinases through rational drug design
GB0030368D0 (en) * 2000-12-13 2001-01-24 Inst Of Molecul & Cell Biology Dormancy-induced mycobacterium proteins
DE60225722T2 (de) 2002-02-08 2009-04-09 The Director, all India Instiute of Medical Science, New Delhi Verfahren zur identifizierung eines neuen ziels zur verwendung bei der entwicklung von gegen tuberkulose wirksamen therapeutischen modalitäten und arzneistoffen

Also Published As

Publication number Publication date
AU2003269346A8 (en) 2004-05-04
US20040209319A1 (en) 2004-10-21
US7566550B2 (en) 2009-07-28
WO2004036224A2 (en) 2004-04-29
EP1554586B1 (de) 2010-03-10
CN1754100A (zh) 2006-03-29
ATE460671T1 (de) 2010-03-15
EP1554586A2 (de) 2005-07-20
AU2003269346A1 (en) 2004-05-04
CN100554966C (zh) 2009-10-28
WO2004036224A3 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
Zhang et al. Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity
Yamaguchi et al. Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor
Galán et al. The cytoskeleton plays a modulatory role in the association between STIM1 and the Ca2+ channel subunits Orai1 and TRPC1
Reszka et al. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis: a link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase
CY1106115T1 (el) Προσδιορισμος κινασης αναπλαστικου λεμφωματος, αντιδραστηρια και συνθεσεις αυτης
DE60039765D1 (de) Konditionelles selex
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
CY1108655T1 (el) ΘΕΙΟΖΟΛΙΔΙΝ-4-ΟΝΕΣ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΠΡΩΤΕΪΝΩΝ hYAK3
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
DK1889920T3 (da) In vitro fremgangsmåde atil identifikation af forbindelse atil cancerterapi
DE60331669D1 (de) Identifikation von Arzneimittel gegen Mykobakterien
DE602004015791D1 (de) Screening-Verfahren zur Identifizierung von Tau-Protein modulierenden Substanzen.
Yang et al. Mass spectrometric quantitation of tubulin acetylation from pepsin-digested rat brain tissue using a novel stable-isotope standard and capture by anti-peptide antibody (SISCAPA) method
Choi et al. Lyso-globotriaosylceramide downregulates KCa3. 1 channel expression to inhibit collagen synthesis in fibroblasts
Tsutsumi et al. The potential role of transient receptor potential type A 1 as a mechanoreceptor in human periodontal ligament cells
Suazo et al. Metabolic labeling with an alkyne probe reveals similarities and differences in the prenylomes of several brain-derived cell lines and primary cells
Puschner et al. Calmodulin-dependent protein kinases mediate calcium-induced slow motility of mammalian outer hair cells
ATE335841T1 (de) Assay zur detektion der transferaseenzymaktivität beim screening von medikamenten
Asteggiano et al. Phosphatidyl inositol‐4, 5‐bisphosphate bound to bovine cardiac Na+/Ca2+ exchanger displays a MgATP regulation similar to that of the exchange fluxes
Akinjiyan et al. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system
DE502005007590D1 (de) Hochempfindliches verfahren zur detektion von unterschieden zwischen den physikalisch messbaren eigenschaften einer probe und einer referenz
WO2004087884A3 (en) TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
SE0104102D0 (sv) New assay
Abe et al. Stellettamide‐A, a novel inhibitor of calmodulin, isolated from a marine sponge
EP2319318A3 (de) Verfahren zur Identifizierung von Verbindungen mit tRNA-Splicing Endonuklease als Aufhänger, und Verwendungen für diese Verbindungen als anti-Proliferationsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition